Diaceutics PLC (LON:DXRX - Get Free Report) insider Nick Roberts acquired 112 shares of the firm's stock in a transaction that occurred on Monday, September 30th. The shares were purchased at an average price of GBX 134 ($1.79) per share, with a total value of £150.08 ($200.75).
Nick Roberts also recently made the following trade(s):
- On Wednesday, August 28th, Nick Roberts purchased 113 shares of Diaceutics stock. The shares were purchased at an average cost of GBX 134 ($1.79) per share, with a total value of £151.42 ($202.54).
Diaceutics Stock Performance
Diaceutics stock opened at GBX 133.50 ($1.79) on Thursday. The company has a market cap of £112.77 million, a price-to-earnings ratio of -4,433.33 and a beta of 0.58. The firm has a 50-day moving average of GBX 128.91 and a 200-day moving average of GBX 120.31. The company has a debt-to-equity ratio of 2.93, a current ratio of 4.85 and a quick ratio of 9.92. Diaceutics PLC has a one year low of GBX 82 ($1.10) and a one year high of GBX 136 ($1.82).
Wall Street Analysts Forecast Growth
Separately, Canaccord Genuity Group reiterated a "buy" rating and issued a GBX 160 ($2.14) price objective on shares of Diaceutics in a report on Tuesday, September 17th.
View Our Latest Report on Diaceutics
Diaceutics Company Profile
(
Get Free Report)
WARNING: “Buffett Indicator” flashing for first time in 50 years
From Behind the Markets | Ad
The stock market collapsed and didn't recover for an entire decade.
And what we're facing today could be even worse.
That's why the actions you take in the next 90 days could be crucial for your financial future.
Take these 4 steps today to protect your retirement NOW
Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
